Evidence map›Paper›PMID 29737630›Full record

ArticleResearch synthesis methods2018

A framework for identifying treatment-covariate interactions in individual participant data network meta-analysis.

S C Freeman, D Fisher, J F Tierney, J R Carpenter

Open access · hybridAbstract read
In one paragraph

Article in Research synthesis methods, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Individual Patient Data Meta-Analysis and Network Meta-Analysis.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

S C FreemanMRC Clinical Trials Unit at UCL, Aviation House, 90 High Holborn, London, WC1V 6LJ, UK.ORCID http://orcid.org/0000-0001-8045-4405
D FisherMRC Clinical Trials Unit at UCL, Aviation House, 90 High Holborn, London, WC1V 6LJ, UK.
J F TierneyMRC Clinical Trials Unit at UCL, Aviation House, 90 High Holborn, London, WC1V 6LJ, UK.
J R CarpenterMRC Clinical Trials Unit at UCL, Aviation House, 90 High Holborn, London, WC1V 6LJ, UK.
MRC Clinical Trials Unit at UCL · GBUniversity of Leicester · GBUniversity of London · GB

Funding

Medical Research Council MC_UU_12023/21Medical Research Council MC_UU_12023/25MRC Clinical Trials Unit Methodology Programme MC UU 12023/21
6 · The paper itself

Abstract

backgroundStratified medicine seeks to identify patients most likely to respond to treatment. Individual participant data (IPD) network meta-analysis (NMA) models have greater power than individual trials to identify treatment-covariate interactions (TCIs). Treatment-covariate interactions contain "within" and "across" trial interactions, where the across-trial interaction is more susceptible to confounding and ecological bias.

methodsWe considered a network of IPD from 37 trials (5922 patients) for cervical cancer (2394 events), where previous research identified disease stage as a potential interaction covariate. We compare 2 models for NMA with TCIs: (1) 2 effects separating within- and across-trial interactions and (2) a single effect combining within- and across-trial interactions. We argue for a visual assessment of consistency of within- and across-trial interactions and consider more detailed aspects of interaction modelling, eg, common vs trial-specific effects of the covariate. This leads us to propose a practical framework for IPD NMA with TCIs.

resultsFollowing our framework, we found no evidence in the cervical cancer network for a treatment-stage interaction on the basis of the within-trial interaction. The NMA provided additional power for an across-trial interaction over and above the pairwise evidence. Following our proposed framework, we found that the within- and across-trial interactions should not be combined.

conclusionAcross-trial interactions are susceptible to confounding and ecological bias. It is important to separate the sources of evidence to check their consistency and identify which sources of evidence are driving the conclusion. Our framework provides practical guidance for researchers, reducing the risk of unduly optimistic interpretation of TCIs.

Indexed as

BiasData Interpretation, StatisticalNetwork Meta-Analysis as TopicFemaleHumansModels, StatisticalRandomized Controlled Trials as TopicReproducibility of ResultsResearch DesignTreatment OutcomeUterine Cervical NeoplasmsframeworkIPDnetwork meta-analysistreatment-covariate interaction

Identifiers

PMID29737630
PMCPMC6159880
OpenAlexW2800879685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.